Transfusion-transmitted cytomegalovirus: lessons from a murine model

Area of Science:

• * Infectious Diseases
• * Immunology
• * Hematology

Background:

• * Transfusion-transmitted cytomegalovirus (CMV) infection (TT-CMV) is a significant risk in blood transfusion recipients, particularly those who are immunocompromised or have immature immune systems.
• * The underlying biological mechanisms of TT-CMV, such as viral latency in donor monocytes and reactivation triggers in recipients, are challenging to investigate directly in human subjects.
• * Understanding these mechanisms is crucial for developing effective prevention strategies.

Purpose of the Study:

• * To review the utility of a mouse blood transfusion model for studying TT-CMV.
• * To explore the biological mechanisms contributing to TT-CMV.
• * To validate novel methods for preventing TT-CMV in at-risk patient populations.

Main Methods:

• * Discussion of a validated mouse model for blood transfusion studies.
• * Application of the model to investigate viral latency and reactivation dynamics.
• * Utilizing the model for preclinical testing of TT-CMV prevention strategies.

Main Results:

• * The mouse model effectively recapitulates key aspects of TT-CMV.
• * It allows for detailed investigation of viral transmission and pathogenesis.
• * The model serves as a platform for evaluating the efficacy of preventative interventions.

Conclusions:

• * Mouse blood transfusion models are valuable tools for elucidating TT-CMV pathogenesis.
• * This model system facilitates the development and validation of TT-CMV prevention strategies.
• * Findings from this model can inform clinical practices to improve transfusion safety for vulnerable populations.